Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Koen van Besien

Showing results (221-230 of 241) with videos related to

Pageof 25
Sort By:
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
Blood Advances|April 3, 2025
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphomaNiloufer Khan, Parastoo B Dahi, Farhad Khimani, et al.
JCI Insight|May 13, 2025
Chemotherapy and the somatic mutation burden of spermShany Picciotto, Camilo Arenas-Gallo, Amos Toren, et al.
Blood Advances|February 25, 2020
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantationDaniel Weisdorf, Sarah Cooley, Tao Wang, et al.
Transplantation and Cellular Therapy|September 10, 2021
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid MalignancyNina Orfali, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failureCésar O Freytes, Mei-Jie Zhang, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic MastocytosisCelalettin Ustun, Jason Gotlib, Uday Popat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphomaSonali M Smith, Linda J Burns, Koen van Besien, et al.
Nature Communications|February 6, 2024
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndromeTerese C Hammond, Marco A Purbhoo, Sapana Kadel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTRHillard M Lazarus, Mei-Jie Zhang, Jeanette Carreras, et al.
Pageof 25

Showing results (221-230 of 241) with videos related to

Sort By:
Pageof 25
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Second autologous stem cell transplantation for relapsed lymphoma after a prior autologous transplantSonali M Smith, Koen van Besien, Jeanette Carreras, et al.
Blood Advances|April 3, 2025
Maintenance therapy with romidepsin after autologous stem-cell transplant for peripheral T-cell lymphomaNiloufer Khan, Parastoo B Dahi, Farhad Khimani, et al.
JCI Insight|May 13, 2025
Chemotherapy and the somatic mutation burden of spermShany Picciotto, Camilo Arenas-Gallo, Amos Toren, et al.
Blood Advances|February 25, 2020
KIR B donors improve the outcome for AML patients given reduced intensity conditioning and unrelated donor transplantationDaniel Weisdorf, Sarah Cooley, Tao Wang, et al.
Transplantation and Cellular Therapy|September 10, 2021
Planned Granulocyte Colony-Stimulating Factor Adversely Impacts Survival after Allogeneic Hematopoietic Cell Transplantation Performed with Thymoglobulin for Myeloid MalignancyNina Orfali, Mei-Jie Zhang, Mariam Allbee-Johnson, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2011
Outcome of lower-intensity allogeneic transplantation in non-Hodgkin lymphoma after autologous transplantation failureCésar O Freytes, Mei-Jie Zhang, Jeanette Carreras, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 2, 2016
Consensus Opinion on Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic MastocytosisCelalettin Ustun, Jason Gotlib, Uday Popat, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 31, 2013
Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphomaSonali M Smith, Linda J Burns, Koen van Besien, et al.
Nature Communications|February 6, 2024
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndromeTerese C Hammond, Marco A Purbhoo, Sapana Kadel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 8, 2010
A comparison of HLA-identical sibling allogeneic versus autologous transplantation for diffuse large B cell lymphoma: a report from the CIBMTRHillard M Lazarus, Mei-Jie Zhang, Jeanette Carreras, et al.
Pageof 25